|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the WBMD DEF 14A filed Nov 5, 2008. Product
Development, Marketing and Related Arrangements
On January 31, 2006, HLTH and WebMD entered into agreements
to support each other’s product development and marketing
of certain product lines. The parties agreed that WebMD would,
in general, manage the product development and marketing of
HLTH’s and WebMD’s product lines in the following
areas:
The agreements provided that HLTH could continue to develop and
market products and services principally provided for internal
use by healthcare payers. The provisions of these agreements
applicable solely to relationships between HLTH and WebMD have
been terminated. However, in connection with the EPS Sale, the
2006 EBS Sale and the 2008 EBS Sale, separate agreements were
entered into with EPS and EBS with respect to certain matters
under those agreements, and the separate agreements continue in
effect with respect to the following products and services:
Table of Contents
These excerpts taken from the WBMD 10-K filed Apr 29, 2008. Product
Development, Marketing and Related Arrangements
On January 31, 2006, HLTH and WebMD entered into agreements
to support each other’s product development and marketing
of certain product lines. The parties agreed that WebMD would,
in general,
Table of Contents
manage the product development and marketing of HLTH’s and
WebMD’s product lines in the following areas:
The agreements provided that HLTH could continue to develop and
market products and services principally provided for internal
use by healthcare payers. The provisions of these agreements
applicable solely to relationships between HLTH and WebMD have
been terminated. However, in connection with the EPS Sale and
the 2006 EBS Sale and 2008 EBS Sale, separate agreements were
entered into with EPS and EBS with respect to certain matters
under those agreements, and the separate agreements continue in
effect with respect to the following products and services:
Product Development, Marketing and Related Arrangements On January 31, 2006, HLTH and WebMD entered into agreements to support each other’s product development and marketing of certain product lines. The parties agreed that WebMD would, in general,
Table of Contentsmanage the product development and marketing of HLTH’s and WebMD’s product lines in the following areas:
The agreements provided that HLTH could continue to develop and market products and services principally provided for internal use by healthcare payers. The provisions of these agreements applicable solely to relationships between HLTH and WebMD have been terminated. However, in connection with the EPS Sale and the 2006 EBS Sale and 2008 EBS Sale, separate agreements were entered into with EPS and EBS with respect to certain matters under those agreements, and the separate agreements continue in effect with respect to the following products and services:
This excerpt taken from the WBMD DEF 14A filed Aug 14, 2007. Product
Development, Marketing and Related Arrangements
On January 31, 2006, HLTH and WebMD entered into agreements
to support each other’s product development and marketing
of certain product lines. The parties agreed that WebMD would,
in general, manage the product development and marketing of
HLTH’s and WebMD’s product lines in the following
areas:
The agreements provided that HLTH could continue to develop and
market products and services that are principally provided for
internal use by healthcare payers and that provide clinical
quality measures of physicians, hospitals and providers, and
analytics and reporting to such payers on the quality of patient
care (we refer to these types of applications as Internal
Clinical Quality Services) and that WebMD may develop and market
its own Internal Clinical Quality Services and that WebMD may,
but is not required to, sell HLTH’s Internal Clinical
Quality Services. The parties have also agreed to work together
to try to develop certain other products and services.
In connection with the EPS Sale, HLTH, WebMD and EPS amended the
existing arrangements applicable to EPS, including by placing
the provisions relating to EPS in a separate agreement. In the
separate agreement, EPS agreed to continue its relationship with
WebMD to exclusively integrate WebMD’s personal health
record with its clinical products, including its electronic
medical record.
In connection with the EBS Sale, HLTH, WebMD and EBS amended the
existing arrangements applicable to EBS, including by placing
the provisions relating to EBS into separate agreements. In the
separate agreements, EBS agreed to continue its strategic
relationships with WebMD and to market WebMD’s online
decision-support platform and tools that support consumer
directed health plans and health savings accounts to its payer
customers for integration into their consumer directed health
plan offerings. In addition, EBS agreed to license certain
de-identified data to HLTH and its subsidiaries, including
WebMD, for use in the
Table of Contents
development and commercialization of certain applications that
use clinical information, including consumer decision-support
applications.
Following the amendments described above, HLTH and WebMD
continue to be parties to a Business Services Agreement. The
terms of this agreement, which will remain in effect until
January 2011, unless terminated earlier in accordance with its
terms, include the following:
Table of Contents
This excerpt taken from the WBMD 10-K filed Apr 30, 2007. Product
Development, Marketing and Related Arrangements
On January 31, 2006, Emdeon and WebMD entered into
agreements to support each other’s product development and
marketing of certain product lines. The parties agreed that
WebMD would, in general, manage the product development and
marketing of Emdeon’s and WebMD’s product lines in the
following areas:
Table of Contents
The agreements provided that Emdeon could continue to develop
and market products and services that are principally provided
for internal use by healthcare payers and that provide clinical
quality measures of physicians, hospitals and providers, and
analytics and reporting to such payers on the quality of patient
care (we refer to these types of applications as Internal
Clinical Quality Services) and WebMD may develop and market its
own Internal Clinical Quality Services and it may, but is not
required to, sell Emdeon’s Internal Clinical Quality
Services. The parties have also agreed to work together to try
to develop certain other products and services.
In connection with the EPS Sale, Emdeon, WebMD and EPS amended
the existing arrangements applicable to EPS, including by
placing the provisions relating to EPS in a separate agreement.
In the separate agreement, EPS agreed to continue its
relationship with WebMD to exclusively integrate WebMD’s
personal health record with its clinical products, including its
electronic medical record.
In connection with the EBS Sale, Emdeon, WebMD and EBS amended
the existing arrangements applicable to EBS, including by
placing the provisions relating to EBS into separate agreements.
In the separate agreements, EBS agreed to continue its strategic
relationships with WebMD and to market WebMD’s online
decision-support platform and tools that support consumer
directed health plans and health savings accounts to its payer
customers for integration into their consumer directed health
plan offerings. In addition, EBS agreed to license certain
de-identified data to Emdeon and its subsidiaries, including
WebMD, for use in the development and commercialization of
certain applications that use clinical information, including
consumer decision-support applications.
Following the amendments described above, Emdeon and WebMD
continue to be parties to a Business Services Agreement. The
terms of this agreement, which will remain in effect until
January 2011, unless terminated earlier in accordance with its
terms, include the following:
Table of Contents
| EXCERPTS ON THIS PAGE:
|
| |||||||
